Vifor Pharma reports strong H1 2021 growth, on track to meet full year guidance1

ST. GALLEN, Switzerland–(BUSINESS WIRE)–Regulatory News: Vifor Pharma Group reported profitable revenue growth in H1 supported by a strong recovery in Ferinject® / Injectafer® wi…